Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells
Proceedings of the National Academy of Sciences · 28.01.2025 · 122 (4)
DOI: 10.1073/pnas.2420005122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.01.2025. Verfasst von Yibi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Extracellular Vesicles, Complement C3, Kidney Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), Start-up Research Fund of Southeast University.
Abstract (Originalsprache)
Heterogeneous roles of complement C3 have been implicated in tumor metastasis and are highly context dependent. However, the underlying mechanisms linking C3 to tumor metastasis remain elusive in renal cell carcinoma (RCC). Here, we demonstrate that C3 of RCC cell-derived extracellular vesicles (EVs) contributes to metastasis via polarizing tumor-associated macrophages (TAMs) into the immunosuppressive phenotype and recruiting polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). Mechanistically, EV C3 induces the secretion of CCL2 and CXCL1 by lung macrophages and subsequently enhances TAM polarization and PMN-MDSC recruitment. Notably, targeting the CCL2/CCR2 or CXCL1/CXCR2 axis with the inhibitors RS504393 or Navarixin, respectively, effectively suppresses lung metastasis induced by RCC-derived C3 in a mouse model. Clinically, RCC patients with high expression of C3 demonstrate poor prognosis. Collectively, our findings reveal that tumor-derived EV C3 induces an immunosuppressive tumor microenvironment via TAMs, and thus promoting RCC metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.
- Key Laboratory of Bio-medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.
- Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Southeast University, Nanjing 210096, China.
- Zhongda Hospital, Medical School, Advanced Institute for Life and Health, Southeast University, Nanjing 210096, China.
- Medical College, Guizhou University, Guiyang 550025, China.
- Medical School of Nanjing University, Nanjing 210046, China.
ORCID-Profile: Xujie Zhao, Shan Gao
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
- Start-up Research Fund of Southeast University
Zitieren
APA
Zhang, Y., Wang, X., Gu, Y., Liu, T., Zhao, X., Cheng, S., Duan, L., Huang, C., Wu, S., & Gao, S. (2025). Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells. Proceedings of the National Academy of Sciences, 122(4). https://doi.org/10.1073/pnas.2420005122
Vancouver
Zhang Y, Wang X, Gu Y, Liu T, Zhao X, Cheng S, et al. Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells. Proceedings of the National Academy of Sciences. 2025;122(4). doi:10.1073/pnas.2420005122
BibTeX
@article{Zhang2025,
author = {Zhang, Yibi and Wang, Xiaodong and Gu, Yinmin and Liu, Tongfeng and Zhao, Xujie and Cheng, Shuwen and Duan, Liqiang and Huang, Chang and Wu, Songzhe and Gao, Shan},
title = {Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {4},
doi = {10.1073/pnas.2420005122}
}
EUVIMED